An experimental study on the correlation between immunosuppression following liver transplantation for liver cancer and tumor growth

肝癌肝移植后免疫抑制与肿瘤生长相关性的实验研究

基本信息

  • 批准号:
    62570615
  • 负责人:
  • 金额:
    $ 1.09万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1987
  • 资助国家:
    日本
  • 起止时间:
    1987 至 1988
  • 项目状态:
    已结题

项目摘要

It is an important problem whether immunosuppression following lover transplantation for liver cancer accelerates tumor growth and induces metastases. In order to clarify the point at issue, an experimental stury was carried out with the use of Wistar rats and the following results were obtained.1. In five rats fed on diet mixed with 3-methyl-4-diaminoazobenzene (DAB), hepatoma developed after feeding for 20 weeks. Whereas hepatoma developed in 1 of 4 rats fed on diet mixed with DAB and Cyclosporin A (Cy A) after 12 weeks. Thus, it was suggested that hepatoma developed in shorter period in rats fed on diet with the immunosuppressive drug.2. Effect of immunosuppression on tumor growth was studied on rats in which rat hepatoma (H-35) cells were injected into the liver. Tumor growth was compared between two groups of rats fed on diets mixed with or without Cyclosporin A. Rats fed on diet with Cy A had larger tumors compared with those fed on normal diet in the examinations performed on 11, 16 and 21 P.O. day.Histologic examinations revealed the difference between the two groups; cancer cells were destroyed in the 8 rats fed on normal diet on 16 and 21 P.O. day, whereas "live" cancer cells were persistent in 1 of 4 rats and in 2 of 4 rats fed on diet with Cy A on 16 and 21 p.o. day respectively. Thus, it was shown that immunosuppression may facilitate tumor growth.
肝癌肝移植后免疫抑制是否会促进肿瘤生长和诱导转移是一个重要的问题。为了阐明这一问题,我们用Wistar大鼠进行了一项实验研究,得到了以下结果.在5只喂食含3-甲基-4-二氨基偶氮苯(DAB)饲料的大鼠中,喂食20周后发生肝癌。12周后,4只大鼠中有1只发生肝癌。因此,提示免疫抑制剂组大鼠肝癌发生时间较短.将大鼠肝癌(H-35)细胞注入大鼠肝脏,研究了免疫抑制对肿瘤生长的影响。比较了两组喂食含或不含环孢菌素A饲料的大鼠的肿瘤生长情况。在术后11、16和21天进行的检查中,与正常饮食喂养的大鼠相比,喂食Cy A饮食的大鼠具有更大的肿瘤。组织学检查揭示了两组之间的差异;在P.O. 16和21,在正常饮食喂养的8只大鼠中癌细胞被破坏。而“活的”癌细胞在16和21 p.o.时在4只大鼠中的1只和4只喂食Cy A饮食的大鼠中的2只中持续存在。天分别。因此,表明免疫抑制可促进肿瘤生长。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
都築俊治: "水本龍二他編集 肝・胆道・膵の手術 適応、手技、pittfallうち左三区域切除" 医学書院, 83-90 (1988)
Shunji Tsuzuki:“Ryuji Mizumoto 等编辑。肝脏、胆道和胰腺手术的适应症、技术和陷阱左三段切除术” Igakushoin,83-90 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuzuki T: "Results of surgical treatment of cancer of the main hepatic duct junction" Kan・Tan・Sui (Japan). 14. 375-382 (1987)
Tsuzuki T:“主肝管交界处癌症的手术治疗结果” Kan·Tan·Sui(日本)14. 375-382(1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
都築俊治 他: 肝と膵. 8. 133-140 (1987)
Toshiharu Tsuzuki 等人:肝脏和胰腺。8. 133-140 (1987)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
都築俊治: "織田敏次監修 臨床肝癌 4 外科 集学的治療のうち 9.閉塞性黄疸型肝癌の切除療法" 講談社, 138-148 (1988)
Toshiharu Tsuzuki:“临床肝癌4外科多学科治疗9.由Toshitsugu Oda监督的阻塞性黄疸型肝癌的切除治疗”讲谈社,138-148(1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
都築俊治 他: 肝臓. 29. 1222-1232 (1988)
T. Tsuzuki 等人:肝脏。29. 1222-1232 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUZUKI Toshiharu其他文献

TSUZUKI Toshiharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUZUKI Toshiharu', 18)}}的其他基金

Detection of hepatitis viruses in liver tissues and clinical characteristics of them.
肝组织中肝炎病毒的检测及其临床特征。
  • 批准号:
    06454388
  • 财政年份:
    1994
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Monitaring of rejection after transplantation by cytokine mRNA mapping
通过细胞因子 mRNA 图谱监测移植后排斥反应
  • 批准号:
    04454336
  • 财政年份:
    1992
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Selection of Candidates for Extensive Liver Resection with Measurement of Functional Reserve of the Remnant Liver.
通过测量残余肝脏的功能储备来选择广泛肝切除术的候选者。
  • 批准号:
    01570766
  • 财政年份:
    1989
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
The clinical and experimental study on the operative procedure of removal of tumor thrombi in the hepatic vein and inferior vena cava in patients with hepatocellular carcinoma
肝细胞癌肝静脉及下腔静脉癌栓清除术的临床及实验研究
  • 批准号:
    60480310
  • 财政年份:
    1985
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
1/4-综合研究:评估综合护理以改善酒精相关性肝病早期肝移植的生物心理社会结果
  • 批准号:
    10712618
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
Addressing Inequity in Liver Transplantation: Application of Artificial Intelligence to Optimize Prioritization on the Waitlist
解决肝移植中的不平等问题:应用人工智能优化候补名单的优先顺序
  • 批准号:
    488363
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Operating Grants
Development and Testing of an Integrated Care Coordination Intervention for Alcohol Use Disorder Recovery after Liver Transplantation
肝移植后酒精使用障碍康复综合护理协调干预措施的开发和测试
  • 批准号:
    10723316
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
A quantitative viability metric for liver transplantation using Resonance Raman Spectroscopy
使用共振拉曼光谱进行肝移植的定量活力指标
  • 批准号:
    10562740
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
3/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
3/4-综合研究:评估综合护理以改善酒精相关性肝病早期肝移植的生物心理社会结果
  • 批准号:
    10710924
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting
调查虚弱对在急症护理环境中接受肝移植的急性肝硬化患者的结局的作用
  • 批准号:
    10658726
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
Immunometabolic impact of machine perfusion strategies in liver transplantation
肝移植中机器灌注策略的免疫代谢影响
  • 批准号:
    MR/X019470/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
    Research Grant
1/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
1/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
  • 批准号:
    10711811
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
4/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
  • 批准号:
    10711018
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
  • 批准号:
    10711001
  • 财政年份:
    2023
  • 资助金额:
    $ 1.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了